
ProMIS Neurosciences
ProMIS Neurosciences develops therapeutic products and diagnostic devices targeting misfolded protein diseases.
Market cap
$37.8m
Enterprise value
$28m
Share price
CAD6.00 PMN.TO
Authorizing premium user...
ProMIS Neurosciences develops therapeutic products and diagnostic devices targeting misfolded protein diseases.